» Articles » PMID: 31502203

Inflammatory Ocular Diseases and Sphingolipid Signaling

Overview
Date 2019 Sep 11
PMID 31502203
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation is a powerful immune countermeasure to tissue damage and infection. The inflammatory response is complex and requires the involvement of myriad signaling pathways and metabolic processes, all governed by a multitude of regulatory systems. Although inflammation is a vital defense against tissue injury and a necessary step in tissue healing, the mechanisms which modulate the initiation, intensity, and duration of this innate immune response can malfunction and result in inappropriate or out-of-control inflammation, even in the absence of an appropriate stimulus. Though the human eye exists in an immune-privileged microenvironment, it is not spared from this. The eye is neither devoid of immune cells nor is it fully sequestered from systemic immune responses, and is therefore fully capable of ruining itself through localized inflammatory dysfunction and systemic inflammatory disease (Taylor AW, Front Immunol 7:37, 2016; Zhou R, Caspi RR, Biol Rep 2, 2010). In fact, a wide range of ocular inflammatory diseases exist and are major causes of blindness in humans. Advances in the understanding of inflammatory processes have revealed new key pathways and molecular factors involved in the mechanisms of inflammation. Lipids and sphingolipids are increasingly being recognized as having important signaling roles in the pathophysiology of ocular inflammatory diseases. What follows below is a discussion of fundamental inflammatory processes, the place of sphingolipids as mediators of said processes, brief descriptions of major inflammatory ocular diseases, and new findings implicating sphingolipids in their pathogenesis.

Citing Articles

Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.

Muniyandi A, Hartman G, Song Y, Mijit M, Kelley M, Corson T J Pharmacol Exp Ther. 2023; 386(1):15-25.

PMID: 37142441 PMC: 10289243. DOI: 10.1124/jpet.122.001563.


A Comprehensive Profiling of Cellular Sphingolipids in Mammalian Endothelial and Microglial Cells Cultured in Normal and High-Glucose Conditions.

Mondal K, Grambergs R, Gangaraju R, Mandal N Cells. 2022; 11(19).

PMID: 36231042 PMC: 9563724. DOI: 10.3390/cells11193082.


The role of sphingolipids in meibomian gland dysfunction and ocular surface inflammation.

Paranjpe V, Galor A, Grambergs R, Mandal N Ocul Surf. 2022; 26:100-110.

PMID: 35973562 PMC: 10259413. DOI: 10.1016/j.jtos.2022.07.006.


Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina.

Mondal K, Porter H, Cole 2nd J, Pandya H, Basu S, Khanam S Mol Neurobiol. 2022; 59(6):3873-3887.

PMID: 35426574 PMC: 10259418. DOI: 10.1007/s12035-022-02825-3.


Human Stem Cell-Derived Retinal Pigment Epithelial Cells as a Model for Drug Screening and Pre-Clinical Assays Compared to ARPE-19 Cell Line.

Oliveira C, Paiva M, Ribeiro M, Andrade G, Carvalho J, Gomes D Int J Stem Cells. 2020; 14(1):74-84.

PMID: 33377455 PMC: 7904525. DOI: 10.15283/ijsc20094.


References
1.
Kim M, Linardic C, Obeid L, Hannun Y . Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem. 1991; 266(1):484-9. View

2.
Taylor A . Ocular Immune Privilege and Transplantation. Front Immunol. 2016; 7:37. PMC: 4744940. DOI: 10.3389/fimmu.2016.00037. View

3.
Toops K, Tan L, Jiang Z, Radu R, Lakkaraju A . Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium. Mol Biol Cell. 2014; 26(1):1-14. PMC: 4279221. DOI: 10.1091/mbc.E14-05-1028. View

4.
Wang H, Feng L, Hu J, Xie C, Wang F . Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry. Exp Eye Res. 2013; 108:110-9. DOI: 10.1016/j.exer.2012.11.023. View

5.
Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M . TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 1992; 71(5):765-76. DOI: 10.1016/0092-8674(92)90553-o. View